A Multicenter, Randomized Clinical Trial Comparing the Three-Weekly Docetaxel Regimen plus Prednisone versus Mitoxantone plus Prednisone for Chinese Patients with Metastatic Castration Refractory Prostate Cancer

PURPOSE: To explore the feasibility and efficacy of docetaxel plus prednisone for Chinese population with metastatic castration refractory prostate cancer (mCRPC). PATIENTS AND METHODS: A total of 228 patients recruited from 15 centers were randomized to receive 10 cycles of D3P arm (docetaxel: 75 m...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Tie, Zeng, Shu-xiong, Ye, Ding-wei, Wei, Qiang, Zhang, Xu, Huang, Yi-ran, Ye, Zhang-qun, Yang, Yong, Zhang, Wei, Tian, Ye, Zhou, Fang-jian, Jie, Jin, Chen, Shi-ping, Sun, Yan, Xie, Li-ping, Yao, Xing, Na, Yan-qun, Sun, Ying-hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307981/
https://www.ncbi.nlm.nih.gov/pubmed/25625938
http://dx.doi.org/10.1371/journal.pone.0117002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307981/
https://www.ncbi.nlm.nih.gov/pubmed/25625938
http://dx.doi.org/10.1371/journal.pone.0117002

Ejemplares similares